Bayer launches Centafore to power clinical imaging

GERMANY – Bayer has officially launched Centafore, a new imaging core lab designed to support clinical trials and the development of Software as a Medical Device (SaMD) across various medical fields.

With over 25 years of in-house experience managing imaging in more than 200 clinical studies, Bayer is now opening its expertise to external partners in the pharmaceutical, biotech, medtech, and digital health industries.

Centafore operates as an imaging contract research organization (iCRO), offering specialized services for image collection, analysis, and interpretation.

It provides expert project management and advanced imaging solutions backed by a global team of board-certified radiologists and imaging specialists working in over 50 countries.

According to Nelson Ambrogio, Bayer’s president of radiology, the launch of Centafore reflects the company’s commitment to improving clinical research through high-quality imaging services.

He emphasized that Centafore aims to boost the accuracy of trial results and help teams make informed decisions in developing new medicines and health technologies.

Centafore’s services cover a wide range of medical fields, including oncology, cardiovascular health, dermatology, central nervous system disorders, pediatrics, women’s health, and digital therapeutics.

It supports imaging needs from early-stage trials to post-marketing studies and ensures compliance in SaMD development.

This launch is part of Bayer’s broader digital health strategy. Centafore was first showcased at ECR 2024 and has already partnered with organizations like OBIO and Luxsonic Technologies to integrate imaging into research and decision-making tools for clinical development.

In another recent move to strengthen its digital health portfolio, Bayer announced plans to acquire HiDoc Technologies GmbH, creators of Cara Care, the first prescription app for treating irritable bowel syndrome (IBS).

The app offers patients a personalized approach to managing symptoms and improving their quality of life.